摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-tert-butyl 3-methyl (3R,4R)-4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate | 1207065-49-3

中文名称
——
中文别名
——
英文名称
1-tert-butyl 3-methyl (3R,4R)-4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate
英文别名
——
1-tert-butyl 3-methyl (3R,4R)-4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate化学式
CAS
1207065-49-3
化学式
C21H29N3O5
mdl
——
分子量
403.478
InChiKey
LUBPTWIRFVXUER-HUUCEWRRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.79
  • 重原子数:
    29.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    82.77
  • 氢给体数:
    0.0
  • 氢受体数:
    7.0

反应信息

  • 作为反应物:
    描述:
    环辛烷甲醛1-tert-butyl 3-methyl (3R,4R)-4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate盐酸三乙酰氧基硼氢化钠 作用下, 以 1,4-二氧六环甲醇N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以80%的产率得到(+/-)-trans-1-(cyclooctylmethyl)-4-(3-ethyl-2-oxo-2,3-dihydrobenzoimidazol-1-yl)piperidine-3-carboxylic acid methyl ester
    参考文献:
    名称:
    Efficient and practical asymmetric synthesis of 1-tert-butyl 3-methyl (3R,4R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate, a useful intermediate for the synthesis of nociceptin antagonists
    摘要:
    An efficient and practical asymmetric synthesis of 1-tert-butyl 3-methyl (3R,4R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate 1, a useful intermediate for the synthesis of nociceptin antagonists, has been developed. This method includes the following key steps: (1) diastereoseiective reduction of a chiral enaminoester 3 having (R)-1-phenylethylamine as a chiral pool constituent with the use of a combined TFA-NaBH4 reduction system and (2) efficient isomerization from 3,4-cis-substituted piperidine 8 to 3,4-trans-substituted piperidine 1 under basic conditions. The above methods proved to be applicable for large-scale operation and hundred grams of enantiomerically pure compound 1 (>98% ee) was obtained. (C) 2009 Published by Elsevier Ltd.
    DOI:
    10.1016/j.tetasy.2009.07.046
  • 作为产物:
    描述:
    1-tert-butyl 3-methyl (3R,4R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate碘乙烷potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以96%的产率得到1-tert-butyl 3-methyl (3R,4R)-4-(3-ethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate
    参考文献:
    名称:
    Efficient and practical asymmetric synthesis of 1-tert-butyl 3-methyl (3R,4R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate, a useful intermediate for the synthesis of nociceptin antagonists
    摘要:
    An efficient and practical asymmetric synthesis of 1-tert-butyl 3-methyl (3R,4R)-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1,3-dicarboxylate 1, a useful intermediate for the synthesis of nociceptin antagonists, has been developed. This method includes the following key steps: (1) diastereoseiective reduction of a chiral enaminoester 3 having (R)-1-phenylethylamine as a chiral pool constituent with the use of a combined TFA-NaBH4 reduction system and (2) efficient isomerization from 3,4-cis-substituted piperidine 8 to 3,4-trans-substituted piperidine 1 under basic conditions. The above methods proved to be applicable for large-scale operation and hundred grams of enantiomerically pure compound 1 (>98% ee) was obtained. (C) 2009 Published by Elsevier Ltd.
    DOI:
    10.1016/j.tetasy.2009.07.046
点击查看最新优质反应信息